Churchill Capital Corp X Warrants Form 4 Filings

Infleqtion, Inc. director Kristina M. Johnson reported option exercises and share sales involving a net sale of 50,000 shares of Common Stock. On 2026-05-28, she exercised stock options to acquire 30,000 shares at an exercise price of $0.90 per share and then sold 30,000 shares in an open-market sale at a weighted average price of about $16.45 per share. On the same date, 20,000 additional shares were sold in open-market transactions at a weighted average price of about $18.00 per share by Catalyzer Ventures, LP Fund I, where she is a general partner and disclaims beneficial ownership except for her pecuniary interest. Following these transactions, she holds 30,000 shares directly, 13,120 shares indirectly through Catalyzer, and stock options for 343,458 shares expiring on 2034-06-05.

Infleqtion, Inc. director David B. Singer reported indirect fund-level transactions in the company’s common stock. On May 27, 2026, investment funds associated with him completed pro rata, no‑consideration share distributions to their limited partners and related restructuring transactions.

On the same date, those funds also executed open‑market sales totaling 3,071,623 shares of Infleqtion common stock at weighted average prices around $15–$16 per share, with sale proceeds distributed to certain limited partners. All holdings are reported as indirect, through Maverick Advisors Fund, Maverick Ventures Investment Fund, Maverick Capital Ventures and family estate planning entities.

Singer is a managing partner of Maverick Ventures and, for Section 16 purposes, disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in the relevant entities.

Infleqtion, Inc. reported insider activity involving Maverick-affiliated funds and entities. On May 27, 2026, they executed open-market sales totaling 3,071,623 shares of Common Stock at weighted average prices of $15.9754 and $15.2879 per share.

Footnotes explain that Maverick Advisors Fund, L.P. and Maverick Ventures Investment Fund, L.P. sold shares and distributed the proceeds to certain limited partners, and also made pro rata share distributions for no consideration. Additional shares were received for no consideration in these pro rata distributions. The reporting owners, including Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie, disclaim beneficial ownership except to the extent of their pecuniary interest.

Infleqtion, Inc. reported a Form 4 showing indirect fund-related sales and restructurings involving its common stock tied to David B. Singer–associated entities. Maverick Advisors Fund and Maverick Ventures Fund distributed shares pro rata to their limited partners for no consideration, and related entities then sold portions of these shares in the open market.

In total, indirectly held entities sold 1,797,637 shares of common stock in open‑market transactions at weighted average prices disclosed in ranges around $16–$18 per share, while 3,840,260 shares were moved through other pro rata distributions and internal restructurings for no consideration. The reporting person states that these positions are held through Maverick funds, Maverick Capital Ventures, family estate‑planning entities, and Maverick Capital Advisors, and disclaims beneficial ownership except to the extent of his pecuniary interest.

Infleqtion, Inc. reported a Form 4 showing multiple indirect transactions by investment entities managed by Maverick. Funds including Maverick Advisors Fund and Maverick Ventures Fund executed open-market sales totaling 1,797,637 shares of common stock on May 29 at weighted average prices around $16–$18 per share, with footnotes noting detailed ranges and that sale proceeds were distributed to certain limited partners. Separate restructuring transactions moved about 4,769,900 shares through pro rata, no‑consideration distributions from these funds and related vehicles, including to managing members and family estate planning entities. The reporting investment advisers and Lee S. Ainslie disclaim beneficial ownership beyond their pecuniary interests, while David B. Singer serves on Infleqtion’s board.

Infleqtion, Inc. director David B. Singer reported internal restructurings of indirect holdings in the company’s common stock. Entities associated with him effected four “J” code transactions on May 27, 2026 involving a total of 4,433,466 shares, all at a stated price of $0.00 per share.

Maverick Advisors Fund and Maverick Ventures Investment Fund made pro rata share distributions to their limited partners for no consideration, and other shares are held by Maverick Capital Ventures, LLC and family estate planning entities controlled by Singer. Following these moves, indirect positions reported include 83,773, 349,693, 2,469,973 and 1,564,321 shares in separate entities.

The filing states that Singer disclaims beneficial ownership of these securities for Section 16 purposes, except to the extent of his pecuniary interest, underscoring that these are entity-level and estate-planning transfers rather than open‑market trading.

Infleqtion, Inc. reported a set of ownership restructuring transactions involving entities associated with Maverick Capital. On May 27, 2026, Maverick Advisors Fund, L.P. and Maverick Ventures Investment Fund, L.P. distributed shares of Infleqtion common stock to their limited partners pro rata for no consideration, and other related entities, including Maverick Ventures and family estate planning entities controlled by Lee S. Ainslie, received shares in these distributions. Following these transactions, indirect holdings reported in the Form 4 include 1,240,622 shares, 349,693 shares, 2,469,973 shares and 1,564,321 shares of common stock across the respective entities, while each reporting owner disclaims beneficial ownership except to the extent of its or his pecuniary interest.

Infleqtion, Inc.’s Chief Revenue Officer Paul Lipman reported a combination of option exercises and share sales. On May 26, 2026, he exercised options to acquire 100,000 shares of common stock at $0.26 per share, then sold 100,000 shares in an open-market transaction at a weighted average price of $15.83 per share, with individual sale prices ranging from $15.735 to $15.99. On May 27, 2026, he exercised additional options to acquire 20,000 shares of common stock at $0.26 per share and held those shares, leaving him with 20,000 common shares directly owned and 535,844 stock options outstanding after these transactions.

Infleqtion, Inc. director and Chief Executive Officer Matthew John Kinsella reported a series of transactions in the company’s common stock. Entities associated with him, including Kinsella Investment Holdings, LLC and family trusts, sold an aggregate of 769,954 shares in open-market transactions at various weighted average prices. He also exercised stock options to acquire 545,824 shares at an exercise price of $0.90 per share. Following these transactions, his reported holdings include 470,143 shares held directly, 336,197 shares held indirectly, and 5,404,556 stock options remaining directly owned.

Infleqtion, Inc. director-linked investment entities reported large open-market sales of Common Stock. Funds associated with director David B. Singer sold a total of 11,619,130 shares on May 21–22, 2026, at prices between $14.6934 and $17.0408 per share. After these transactions, entities associated with Singer continued to hold 3,115,342 shares indirectly following one of the May 22 trades, while several other fund positions were reduced to zero.

Infleqtion, Inc. reported a large insider transaction by Maverick-affiliated investment vehicles. On May 21–22, 2026, entities managed by Maverick Capital executed open‑market sales totaling 11,907,630 shares of Infleqtion common stock, at reported prices around $14.6934 and $17.0408 per share.

The shares were held indirectly through various Maverick-managed funds and separate accounts, and each reporting owner disclaims beneficial ownership beyond its pecuniary interest. After these sales, certain Maverick-related accounts still report multi‑million‑share indirect positions, including 7,554,800 and 4,784,711 shares in individual accounts.

Infleqtion, Inc. reported that its Chief Financial Officer, Ilan Hart, received a grant of 338,983 shares of common stock in the form of restricted stock units (RSUs) at a price of $0.00 per share. Following this award, he directly holds 338,983 common shares subject to vesting.

According to the award terms, one quarter of the RSUs will vest on November 1, 2026, and three forty-eighths (3/48ths) of the RSUs will vest in equal quarterly installments after that date, contingent on his continued service under the company’s 2026 Equity Incentive Plan. Each RSU converts into one share of Infleqtion common stock upon vesting.

Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.

Infleqtion, Inc. granted Chief Legal Officer Jason Dean Hall an award of 211,864 shares of common stock in the form of restricted stock units (RSUs) at no cash cost per share. Each RSU represents a right to receive one share of Infleqtion common stock.

According to the vesting schedule, one quarter of the RSUs will vest on November 10, 2026, and three forty-eighths will vest in equal quarterly installments after that, so long as Hall maintains continuous service under the company's 2026 Equity Incentive Plan. After this award, he directly holds 211,864 shares reported in this filing.

Infleqtion, Inc. insider filings show a major restructuring by LCP Quantum investment funds associated with manager Tyler Brous. On April 23, 2026, these funds completed “other” transactions that together reclassified and distributed 30,528,914 shares of Common Stock to their own investors, pro rata and without consideration.

Because the funds distributed the shares they had held directly, the reporting persons are no longer deemed 10% owners and are no longer subject to Section 16(a) for Infleqtion securities. A related entry on April 22, 2026 shows Tyler Brous holding 1,403,922 Common shares directly after a change in the form of beneficial ownership from indirect to direct under Rule 16a-13.

Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options vest in full on the earlier of May 23, 2027 or the issuer's next annual stockholder meeting after April 10, 2026, subject to his continuous service. These options expire on April 10, 2036. According to the disclosure, the economic benefit of this director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.

Infleqtion, Inc. reported that director David B. Singer received a grant of stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options were awarded at no cost and expire on April 10, 2036.

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to Mr. Singer’s continued board service. After this grant, 33,928 derivative securities of this type are reported as beneficially owned indirectly.

Infleqtion, Inc. director David B. Singer received a grant of stock options covering 33,928 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036.

These options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan. Vesting may accelerate under the Non-Employee Director Compensation Policy.

Infleqtion, Inc. director Dawn Clawson Meyerriecks received a grant of stock options as equity compensation. She was awarded 33,928 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036. Following this grant, she holds 33,928 derivative securities linked to common stock.

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026, subject to her continued service under the company’s 2026 Equity Incentive Plan and any acceleration provisions in the Non-Employee Director Compensation Policy.

Infleqtion, Inc. director Kristina M. Johnson received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. After this grant, she holds 22,619 derivative securities of this type.

The options vest in full on the earlier of May 23, 2027 or the company’s next annual stockholders’ meeting following April 10, 2026, subject to her continuous service under Infleqtion’s 2026 Equity Incentive Plan and its Non-Employee Director Compensation Policy.

Infleqtion, Inc. director James Eric Bjornholt received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. They vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan.

Infleqtion, Inc. director Catherine P. Lego received a grant of stock options as part of her compensation. She was awarded 22,619 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036.

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, provided she maintains continuous service under the company’s 2026 Equity Incentive Plan. After this grant, she directly holds options for 22,619 shares.

Infleqtion, Inc. director James Eric Bjornholt reported receiving a grant of stock options covering 29,950 shares of Common Stock on February 13, 2026. The options have an exercise price of $13.22 per share and expire on February 12, 2036.

According to the filing, one-third of the underlying shares vest on December 21, 2026, with 1/36 of the total vesting each month thereafter, subject to his continued service. This amendment also corrects a prior scrivener’s error in the originally reported first exercisable date.

Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.

The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.

Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.

Infleqtion, Inc. director Kristina M. Johnson reported equity awards linked to the merger of Churchill Capital Corp X with ColdQuanta. She was granted 373,458 stock options at an exercise price of $0.00 per share, which vest monthly from June 1, 2024 in 36 equal installments, contingent on continued service.

Johnson also reported an acquisition of 33,120 shares of common stock for $0.00 per share. These shares are held indirectly by Catalyzer Ventures, LP Fund I, over which she has voting and investment power and may therefore be deemed a beneficial owner.

Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant. He acquired a stock option covering 29,950 shares of the company’s stock. According to the vesting terms, one-third of the option vests on February 17, 2027, and the remaining shares vest in equal monthly installments over the following three years, conditioned on his continued service.

Catherine P. Lego, a director of Infleqtion, Inc. (formerly Churchill Capital Corp X), reported stock awards tied to the company’s merger with ColdQuanta, Inc. She acquired 477,680 shares of common stock directly and 82,801 shares indirectly through Lego Holdings, LP as merger consideration.

Footnotes state these shares were issued upon conversion of the Company’s Series C-1 preferred stock in the completed merger structure. Of the reported shares, 103,739 are subject to Infleqtion’s right of repurchase and vest monthly in equal installments until December 10, 2026, contingent on her continued service.

Infleqtion, Inc. (formerly Churchill Capital Corp X) reported that Chief Revenue Officer Paul Lipman received multiple grants of stock options on February 13, 2026. These derivative awards include a grant for 555,844 stock options and several additional option grants at an exercise price of $0.00 per share.

According to the disclosure, the options were received in connection with merger transactions completed under a September 8, 2025 agreement, where legacy ColdQuanta, Inc. options were converted into Infleqtion options with the same terms and conditions. Some options are fully vested, while others vest in equal monthly installments beginning on February 17, 2026, contingent on continued service.

Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.

Churchill Capital Corp X granted Chief Legal Officer Jason Dean Hall a stock option covering 262,722 shares of common stock. This is a compensatory award rather than an open-market purchase.

According to the award terms, one quarter of the option vests on November 10, 2026. The remaining portion vests in equal monthly installments of 1/48 of the total shares on the same day of each following month, conditioned on Hall’s continued service with the company through each vesting date.

Infleqtion, Inc. (formerly Churchill Capital Corp X) Chief Technology Officer Pranav Gokhale reported equity awards received on February 13, 2026. He acquired 2,338,980 shares of common stock at a price of $0.00 per share, plus stock options covering an additional 559,367 shares. Some options are already vested, while others vest in equal monthly installments beginning on February 17, 2026, subject to continued service. Several of these awards reflect legacy ColdQuanta equity that was converted into Infleqtion stock and options in connection with the company’s merger transaction.

Infleqtion, Inc.’s Chief Executive Officer and director Matthew John Kinsella reported multiple equity awards dated February 13, 2026. He received a stock option for 5,950,380 shares and another option for 481,727 shares, both granted at an exercise price of $0.00 per share. Some of these options vest monthly, with a portion accelerated at the closing of prior mergers, and legacy ColdQuanta options were converted into Infleqtion options on the same terms. Kinsella also reported indirect acquisitions of common stock awards of 560,327, 34,740 and 101,882 shares, held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts over which he has voting and investment power.

Infleqtion, Inc. reported that entities associated with sponsor Churchill Sponsor X LLC indirectly acquired 10,650,000 shares of common stock on February 12, 2026 through a conversion of Class B ordinary shares following its business combination with Legacy Infleqtion.

The filing explains that Churchill Capital Corp X was domesticated from the Cayman Islands to Delaware, and its Class B and Class A shares automatically converted into Infleqtion common stock on a one-to-one basis. Churchill Sponsor X LLC now indirectly holds these common shares and 75,000 warrants, while Michael Klein and related entities disclaim beneficial ownership beyond their pecuniary interests.